Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "Pharmacologic Substance[C1909]|Biological Agent[C307]|Antineoplastic Biological Agent" in comments (approximate match)

Showing 141 - 150 of 183 results

First page
Previous page
Next page
Next page

ONARTUZUMAB

MS1J9720WC

Subunit 1 (449) Similarity Search Subunit 2 (227) Similarity Search Subunit 3 (220) Similarity Search

Sequence Search

Subunit 1 (449) Similarity Search Subunit 2 (227) Similarity Search Subunit 3 (220) Similarity Search

Status:

Investigational

Source:

NCT02488330: Phase 3 Interventional Completed Solid Tumor

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02488330

Class:

PROTEIN

ICRUCUMAB

T7H0B1R64U

Subunit 1 (456) Similarity Search Subunit 2 (456) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Sequence Search

Subunit 1 (456) Similarity Search Subunit 2 (456) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Status:

Investigational

Source:

NCT01282463: Phase 2 Interventional Completed Carcinoma of Urinary Tract

(2011)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01282463

Class:

PROTEIN

ENSITUXIMAB

F988K568V2

Subunit 1 (443) Similarity Search Subunit 2 (443) Similarity Search Subunit 3 (213) Similarity Search Subunit 4 (213) Similarity Search

Sequence Search

Subunit 1 (443) Similarity Search Subunit 2 (443) Similarity Search Subunit 3 (213) Similarity Search Subunit 4 (213) Similarity Search

Status:

Investigational

Source:

NCT01040000: Phase 1/Phase 2 Interventional Completed Metastatic Pancreatic Cancer

(2012)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01040000

Class:

PROTEIN

DALOTUZUMAB

6YI1L648RH

Subunit 1 (447) Similarity Search Subunit 2 (447) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Sequence Search

Subunit 1 (447) Similarity Search Subunit 2 (447) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Status:

Investigational

Source:

NCT01605396: Phase 2 Interventional Completed Breast Neoplasms

(2012)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01605396

Class:

PROTEIN

ABITUZUMAB

724QD330RD

Subunit 1 (447) Similarity Search Subunit 2 (447) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (447) Similarity Search Subunit 2 (447) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT01360840: Phase 2 Interventional Completed Prostate Cancer Metastatic

(2011)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01360840

Class:

PROTEIN

CONATUMUMAB

1P48L61KM0

Subunit 1 (452) Similarity Search Subunit 2 (452) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Sequence Search

Subunit 1 (452) Similarity Search Subunit 2 (452) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Status:

Investigational

Source:

NCT01327612: Phase 2 Interventional Completed Advanced Solid Tumors

(2011)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01327612

Class:

PROTEIN

FRESOLIMUMAB

375142VBIA

Subunit 1 (447) Similarity Search Subunit 2 (447) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Sequence Search

Subunit 1 (447) Similarity Search Subunit 2 (447) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Status:

Investigational

Source:

NCT01665391: Phase 2 Interventional Completed Primary Focal Segmental Glomerulosclerosis

(2012)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01665391

Class:

PROTEIN

PATISIRAN

50FKX8CB2Y

Sequence Search

Status:

US Approved Rx (2018)

Source:

NDA210922

(2018)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210922

First approved in 2018

Source:

NDA210922

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210922

Class:

NUCLEIC ACID

TALIMOGENE LAHERPAREPVEC

07730V90L6

Sequence Search

Status:

US Approved Rx (2015)

Source:

BLA125518

(2015)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2015

Source:

BLA125518

Source URL:

https://www.fda.gov/media/113210/download

Class:

NUCLEIC ACID

SIG12D LODER

NNQ0PKZ9EV

Sequence Search

Status:

Investigational

Source:

NCT01188785: Phase 1 Interventional Completed Pancreatic Ductal Adenocarcinoma

(2011)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01188785

Class:

NUCLEIC ACID

Protein

Protein

Protein

Protein

Protein

Protein

Protein

Nucleic Acid

07730V90L6
Not a public record

Nucleic Acid

TALIMOGENE LAHERPAREPVEC

Nucleic Acid

Showing 141 - 150 of 183 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1